SCHEMBL5022113

SCHEMBL5022113

C[C@@H](I)c1cccc(F)c1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
IDO1 P14902 1/20 0.44
TDO2 P48775 1/20 0.44
CES2 O00748 1/20 0.43
CES1 P23141 1/20 0.43
AOC3 Q16853 1/20 0.42
MTOR P42345 1/20 0.39
NFE2L2 Q16236 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
CASR P41180 1/20 0.37
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18077984 1.00 ACHE (0.44) ACHEHDAC4HDAC7HDAC5IDO1
SCHEMBL22288271 0.83 HDAC4 (0.37) HDAC4
SCHEMBL179253 0.81 ACHE (0.48) ACHEHDAC4HDAC7HDAC5IDO1
SCHEMBL792296 0.81 ACHE (0.48) ACHEHDAC4HDAC7HDAC5IDO1
SCHEMBL23343758 0.79 PGK1 (0.39) HDAC4
Ammonia Solution, Strong SCHEMBL6000669 0.79 ACHE (0.46) ACHEHDAC4HDAC7HDAC5IDO1
SCHEMBL17591473 0.79 ACHE (0.46) ACHEHDAC4HDAC7HDAC5IDO1
SCHEMBL18372950 0.78 HDAC4 (0.46) ACHEHDAC4HDAC7HDAC5IDO1
SCHEMBL4702366 0.78 HDAC4 (0.48) ACHEHDAC4HDAC7HDAC5IDO1
SCHEMBL17069219 0.77 AOC3 (0.46) ACHEHDAC4HDAC7HDAC5IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2638014-B1 N-SULFONYLATED TETRAHYDROQUINOLINES AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF ROR-GAMMA ACTIVITY AND THE TREATMENT OF DISEASES LYCERA CORP (US) 2017-01-04 EP disclosed
WO-2012064744-A2 TETRAHYDROQUINOLINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORϒ ACTIVITY AND THE TREATMENT OF DISEASE LYCERA CORPORATION (US) 2012-05-18 WO disclosed